Phase II trial of neoadjuvant capecitabine (C) with irinotecan (I) followed by capecitabine-based chemoradiotherapy (CRT) for patients (pts) with locally advanced rectal cancer (LARC): HOG GI03-53

被引：0
|
作者：
Cardenes, H. R.
Sanghani, S.
Burns, M.
Robb, M.
Hinkle, D. T.
Johnson, C. S.
Yu, M.
Currie, C. R.
Loehrer, P. J.
Chiorean, E. G.
机构：
[1] Indiana Univ, Simon Canc Ctr, Indianapolis, IN 46204 USA
[2] Indiana Univ Sch Med, Indianapolis, IN 46202 USA
[3] Hoosier Oncol Grp, Indianapolis, IN USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2010年 / 28卷 / 15期
关键词：
D O I：
10.1200/jco.2010.28.15_suppl.e14026
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e14026
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Phase II and gene expression analysis trial of neoadjuvant capecitabine plus irinotecan followed by capecitabine-based chemoradiotherapy for locally advanced rectal cancer: Hoosier Oncology Group GI03-53
    Chiorean, E. Gabriela
    Sanghani, Sonal
    Schiel, Marissa A.
    Yu, Menggang
    Burns, Matthew
    Tong, Yan
    Hinkle, David T.
    Coleman, Nicki
    Robb, Bruce
    LeBlanc, Julia
    Clark, Romnee
    Bufill, Jose
    Curie, Colleen
    Loehrer, Patrick J.
    Cardenes, Higinia
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2012, 70 (01) : 25 - 32
  • [2] Phase II and gene expression analysis trial of neoadjuvant capecitabine plus irinotecan followed by capecitabine-based chemoradiotherapy for locally advanced rectal cancer: Hoosier Oncology Group GI03-53
    E. Gabriela Chiorean
    Sonal Sanghani
    Marissa A. Schiel
    Menggang Yu
    Matthew Burns
    Yan Tong
    David T. Hinkle
    Nicki Coleman
    Bruce Robb
    Julia LeBlanc
    Romnee Clark
    Jose Bufill
    Colleen Curie
    Patrick J. Loehrer
    Higinia Cardenes
    Cancer Chemotherapy and Pharmacology, 2012, 70 : 25 - 32
  • [3] Phase II Trial of Neoadjuvant Capecitabine (Cp) with Irinotecan (Ir) followed by Capecitabine-based Chemoradiotherapy (CRT) for Patients (pts) with Locally Advanced Rectal Cancer (LARC): A Hoosier Oncology Group Study
    Cardenes, H.
    Sanghani, S.
    Burns, M.
    Robb, B.
    Hinkle, D.
    Johnson, C.
    Yu, M.
    Currie, C.
    Loehrer, P.
    Chiorean, E.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2010, 78 (03): : S54 - S54
  • [4] Intensified neoadjuvant chemoradiotherapy (CRT) with capecitabine and irinotecan in patients with locally advanced rectal cancer (LARC): A phase I/II study.
    Klautke, G
    Foitzik, T
    Ludwig, K
    Klar, EJM
    Fietkau, R
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 292S - 292S
  • [5] Phase II study of neoadjuvant irinotecan, capecitabine, oxaliplatin (IXO) followed by chemoradiotherapy (CRT) using concurrent capecitabine for resectable locally advanced rectal cancer
    Jonker, Derek J.
    Maroun, Jean Alfred
    Auer, Rebecca Ann C.
    Yarom, Nirit
    Marginean, Celia
    Shabana, Weal
    Pantarotto, Jason R.
    Asmis, Timothy R.
    Boushey, Robin P.
    Goodwin, Rachel Anne
    Kendal, Wayne
    Tadros, Shaheer
    Grimard, Laval Jacques
    Moloo, Husein
    Friedlich, Martin
    Bohemier, Caryn
    Marginean, Horia
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [6] Phase I trial of neoadjuvant chemoradiotherapy (CRT) with capecitabine and weekly irinotecan followed by laparoscopic total mesorectal excision (LTME) in rectal cancer patients
    Ugidos, Lisardo
    Delgado, Salvadora
    Conill, Carlos
    Gines, Angels
    Gallego, Rosa
    Ayuso, Juan Ramon
    Miquel, Rosa
    Tosca, Monica
    de Lacy, Antonio
    Castells, Antoni
    Maurel, Joan
    INVESTIGATIONAL NEW DRUGS, 2009, 27 (03) : 262 - 268
  • [7] Phase I trial of neoadjuvant chemoradiotherapy (CRT) with capecitabine and weekly irinotecan followed by laparoscopic total mesorectal excision (LTME) in rectal cancer patients
    Lisardo Ugidos
    Salvadora Delgado
    Carlos Conill
    Angels Ginés
    Rosa Gallego
    Juan Ramón Ayuso
    Rosa Miquel
    Monica Tosca
    Antonio de Lacy
    Antoni Castells
    Joan Maurel
    Investigational New Drugs, 2009, 27 : 262 - 268
  • [8] Phase II study of capecitabine-based concomitant chemoradiation followed by durvalumab as a neoadjuvant strategy in locally advanced rectal cancer: the PANDORA trial
    Grassi, E.
    Zingaretti, C.
    Petracci, E.
    Corbelli, J.
    Papiani, G.
    Banchelli, I.
    Valli, I.
    Frassineti, G. L.
    Passardi, A.
    Di Bartolomeo, M.
    Pietrantonio, F.
    Gelsomino, F.
    Carandina, I.
    Banzi, M.
    Martella, L.
    Bonetti, A., V
    Boccaccino, A.
    Molinari, C.
    Marisi, G.
    Ugolini, G.
    Nanni, O.
    Tamberi, S.
    ESMO OPEN, 2023, 8 (05)
  • [9] PHASE I/II TRIAL OF PERIOPERATIVE OXALIPLATIN (O), CAPECITABINE (C) AND IRINOTECAN (I) FOR PATIENTS (PTS) WITH LOCALLY ADVANCED GASTRIC CANCER
    Utelbayeva, A.
    Arzykulov, Z.
    Izhanov, E.
    ANNALS OF ONCOLOGY, 2010, 21 : 45 - 46
  • [10] A Phase I Study of Neoadjuvant Capecitabine, Oxaliplatin, and Irinotecan (XELOXIRI) in Patients with Locally Advanced Rectal Cancer
    Kudo, Toshihiro
    Takemasa, Ichiro
    Hata, Tsuyoshi
    Sakai, Daisuke
    Takahashi, Hidekazu
    Haraguchi, Naotsugu
    Nishimura, Junichi
    Hata, Taishi
    Matsuda, Chu
    Satoh, Taroh
    Mizushima, Tsunekazu
    Mori, Masaki
    Doki, Yuichiro
    ONCOLOGY, 2019, 97 (04) : 211 - 216
12345